Search results
Displaying 21 - 30 of 37 results
- Benefits and risks of taking anti-seizure medicines for epilepsy, mental health, or pain
-
Safe use of opioids data collection and reporting workbook (manual data capture)
Spreadsheet template for manual data capture, for the safe use of opioids data collection and reporting.
-
Evaluation of the safe use of opioids national collaborative
This report presents an evaluation of the Health Quality & Safety Commission-led safe use of opioids national collaborative.
-
Pharmac leaflet explaining medicine brand changes
This leaflet from Pharmac explains why brand names, appearance and packaging of your medicines may have changed.
-
Metoprolol oral administration - draft alert
The Medication Safety Expert Advisory Group is developing a full alert following release of a safety signal issued in October 2012 on oral metoprolol administration.
-
Medicine reconciliation guidance tools and training materials
Medicine reconciliation guidance tools and training materials.
-
Oxycodone: How did we get here and how do we fix it
This article from Best Practice Journal (July 2014) 'How did we get here and how do we fix it' focuses on the increase in prescribing of oxycodone.
-
Safety Signal: Changes to the labelling of Bicillin LA®
Following international practice, the name and strength description for Bicillin LA® has been changed. The expression of the name will now be benzathine benzylpenicillin tetrahydrate. The expression of product strength will now be 1,200,000 units/2.3
-
Opioid implementation package
This package outlines the next steps and what the options are to make a significant difference in opioid-induced adverse drug events.
-
Patient information - Help us to help you
A leaflet about medicines safety for patients coming into hospital.